Table 1.
Characteristics of the study population.
| T2DM group (n = 15) |
IFG group (n = 22) |
NFG group (n = 24) |
Control (n = 20) |
|
|---|---|---|---|---|
| Age (years) | 48.1 ± 6.5 | 51.5 ± 4.9 | 48.1 ± 5.9 | 45.5 ± 7.1 |
| Body mass (kg) | 103.3±13.9** ǂ | 101.4 ± 18.2** | 91.8 ± 14.1** | 59.9 ± 7..4 |
| BMI (kg/m2) | 39.8 ± 4.8** | 38.3 ± 6.4** | 35.1 ± 5.1** | 22.1 ± 2.8 |
| Fat mass (%) | 51.8 ± 5.7** ǂ | 51.1 ± 5.6** ǂ | 46.7 ± 7.3 ** | 28.5± 8.8 |
| Waist circumference (cm) | 108.2 ± 7.9** | 110.3 ± 12.4** | 102.9 ± 12.9** | 74.1 ± 6.2 |
| Systolic BP (mmHg)] | 142.7 ± 22.5** | 143.6 ± 13.1** | 114.5 ± 14.5 | 104.3 ± 8.7 |
| Diastolic BP (mmHg) | 87.1 ± 12.6** | 86.0 ± 8.9** | 74.8 ± 10.2 | 68.6 ± 6.1 |
| Total cholesterol (mg/dL) | 261.4 ± 66.1** | 239.6 ± 40.9** | 216.3 ± 37.9 | 187.9 ± 20.1 |
| HDLC (mg/dL) | 41.4 ± 10.1* #˧ | 53.0 ± 14.6** | 53.5 ± 16.1 | 62.1 ± 12.1 |
| LDLC (mg/dL) | 198.7 ± 68.4 *˧ | 151.5 ± 41.3** | 141.1 ± 40.1 | 129.8 ± 36.9 |
| Triglycerides (mg/dL) | 155.1 ± 69.9** ǂ | 154.5± 100.2**ǂ | 110.5 ± 31.8 | 79.0 ± 26.2 |
| Fasting glucose (mg/dL) | 138.3 ± 23** ## ǂ | 102.4± 11.4 * | 91.7 ± 6.3 | 86.4 ± 10.2 |
| Fasting insulin (μlU/mL) | 21.2 ± 14.9** ǂ | 16.2 ± 5.8 ** ǂ | 7.1 ± 3.1 | 6.3 ± 3.1 |
| HOMA-IR | 6.1 ± 5.7** ǂ | 4.1 ± 1.5** ǂ | 1.6 ± 0.7 | 1.4 ± 0.6 |
| C-peptide (nmol/L) | 1.52 ± 0.64* | 1.10 ± 0.47 | 0.86±0.32 | 0.83 ± 0.4 |
Data are presented as mean ± SD.
* p < 0.05; ** p < 0.001 vs control; # p < 0.05, ## p < 0.001 vs IFG; ˧ p < 0.05, ǂ p < 0.001 vs NFG